Dysregulation of the NF-κB signaling pathway has been associated with initiation and progression of IBD, and excessive production of pro-inflammatory cytokines due to abnormal activation of NF-κB signaling has been correlated with inflammation in the intestine (Han et al., 2017). The gene discussed is NFKB1; the disease is inflammatory bowel disease.